Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Ellen M. Apperloo, José Luis Górriz, María José Soler, Secundino Cigarrán Guldris, Josep M. Cruzado, María Jesús Puchades, Marina López-Martínez, Femke Waanders, Gozewijn D. Laverman, Annemarie van der Aart-van der Beek, Klaas Hoogenberg, André P. van Beek, Jacobien C. Verhave, Sofia B. Ahmed, Roland E. Schmieder, Christoph Wanner, David Z.I. Cherney, Niels Jongs, Hiddo J.L. Heerspink